These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31144461)

  • 1. Loss of cell polarity regulated by PTEN/Cdc42 enrolled in the process of Hepatopulmonary Syndrome.
    Gao J; Yu H; Bai X; Liu C; Chen L; Belguise K; Wang X; Lu K; Hu Z; Yi B
    J Cell Mol Med; 2019 Aug; 23(8):5542-5552. PubMed ID: 31144461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 protein regulates the expression of PMVEC cytoskeletal proteins in CBDL rat serum-induced pulmonary microvascular remodeling.
    Yi B; Zeng J; Wang G; Qian G; Lu K
    J Transl Med; 2013 Apr; 11():98. PubMed ID: 23587191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of autophagy ameliorates pulmonary microvascular dilation and PMVECs excessive proliferation in rat experimental hepatopulmonary syndrome.
    Xu D; Chen B; Gu J; Chen L; Belguise K; Wang X; Yi B; Lu K
    Sci Rep; 2016 Aug; 6():30833. PubMed ID: 27480323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A2 inhibits the migration of PASMCs stimulated with HPS rat serum by down-regulating the expression of paxillin.
    Chen Y; Wen X; Wang Z; Zeng J; Chen B; Yang Y; Lu K; Gu J; Yi B
    Biochem Biophys Res Commun; 2016 Jan; 469(1):70-75. PubMed ID: 26616057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-199a-5p Regulates the Proliferation of Pulmonary Microvascular Endothelial Cells in Hepatopulmonary Syndrome.
    Zeng J; Chen L; Chen B; Lu K; Belguise K; Wang X; Yi B
    Cell Physiol Biochem; 2015; 37(4):1289-300. PubMed ID: 26430741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
    Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
    J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 promotes pulmonary intravascular macrophage accumulation by exacerbating BMP signaling in rat experimental hepatopulmonary syndrome.
    Liu C; Gao J; Chen B; Chen L; Belguise K; Yu W; Lu K; Wang X; Yi B
    Biochem Pharmacol; 2017 Aug; 138():205-215. PubMed ID: 28642034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenic protein-2 regulates the myogenic differentiation of PMVECs in CBDL rat serum-induced pulmonary microvascular remodeling.
    Liu C; Chen L; Zeng J; Cui J; Ning JN; Wang GS; Belguise K; Wang X; Qian GS; Lu KZ; Yi B
    Exp Cell Res; 2015 Aug; 336(1):109-18. PubMed ID: 26071935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
    Zhu J; Qiu J; Chen K; Wang W; Zheng S
    Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
    Chen B; Ning JL; Gu JT; Cui J; Yang Y; Wang Z; Zeng J; Yi B; Lu KZ
    Liver Int; 2015 Apr; 35(4):1373-82. PubMed ID: 25113058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.
    Shen CC; Chen B; Gu JT; Ning JL; Zeng J; Yi B; Lu KZ
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):676-684. PubMed ID: 29233725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2 macrophage accumulation contributes to pulmonary fibrosis, vascular dilatation, and hypoxemia in rat hepatopulmonary syndrome.
    Chen B; Yang Y; Yang C; Duan J; Chen L; Lu K; Yi B; Chen Y; Xu D; Huang H
    J Cell Physiol; 2021 Nov; 236(11):7682-7697. PubMed ID: 34041750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
    Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of annexin A2 on hepatopulmonary syndrome rat serum-induced proliferation of pulmonary arterial smooth muscle cells.
    Zeng J; Yi B; Wang Z; Ning J; Wang X; Lu K
    Respir Physiol Neurobiol; 2013 Jan; 185(2):332-8. PubMed ID: 23059374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-101 inhibits proliferation of pulmonary microvascular endothelial cells in a rat model of hepatopulmonary syndrome by targeting the JAK2/STAT3 signaling pathway.
    Wang L; Zhuang L; Rong H; Guo Y; Ling X; Wang R; Yu X; Zhang W
    Mol Med Rep; 2015 Dec; 12(6):8261-7. PubMed ID: 26498873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-like factor 6 mediates pulmonary angiogenesis in rat experimental hepatopulmonary syndrome and is aggravated by bone morphogenetic protein 9.
    Yang Y; Yu H; Yang C; Zhang Y; Ai X; Wang X; Lu K; Yi B
    Biol Open; 2019 Jun; 8(6):. PubMed ID: 31189661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated circulating BMP9 aggravates pulmonary angiogenesis in hepatopulmonary syndrome rats through ALK1-Endoglin-Smad1/5/9 signalling.
    Yang C; Sun M; Yang Y; Han Y; Wu X; Wu X; Cao H; Chen L; Lei Y; Hu X; Chen Y; Zeng Z; Li J; Shu X; Yang Z; Lu K; Li Y; Wang X; Yi B
    Eur J Clin Invest; 2024 Aug; 54(8):e14212. PubMed ID: 38591651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome.
    Wu W; Zhang J; Yang W; Hu B; Fallon MB
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1888-1894. PubMed ID: 27029414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2.
    Yang C; Lv K; Chen B; Yang Y; Ai X; Yu H; Yang Y; Yi B; Lu K
    Exp Cell Res; 2018 Apr; 365(1):24-32. PubMed ID: 29453975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-206 controls the phenotypic modulation of pulmonary arterial smooth muscle cells induced by serum from rats with hepatopulmonary syndrome by regulating the target gene, annexin A2.
    Chen L; Li YS; Cui J; Ning JN; Wang GS; Qian GS; Lu KZ; Yi B
    Cell Physiol Biochem; 2014; 34(5):1768-79. PubMed ID: 25427750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.